As an example, the AML1-ETO fusion protein found in patients with t (8; 21) AML is recruiting several HDACs enzymes that will repress AML1 target genes, thus preventing myeloid differentiation and inducing cellular transformation [17]. This evidence concerns the gene RUNX1 and acute myeloid leukemia.